2019
DOI: 10.1016/j.hlc.2018.02.005
|View full text |Cite
|
Sign up to set email alerts
|

Thoracoscopic Sympathectomy for Long QT Syndrome. Literature Review and Case Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 20 publications
0
9
0
1
Order By: Relevance
“…Persistent CSD is achieved at open surgery (or by video-assisted thoracoscopy) by resecting the lower third to half of the stellate ganglia and the T2 to T4 or T5 thoracic ganglia, as well as transecting the nerve of Kuntz when present ( S9.16.10 ). Potential complications include Horner syndrome, Harlequin syndrome, dyshydrosis, and regional temperature changes ( S9.16.11 , S9.16.12 ). In a series of heterogeneous patients with drug-refractory VA storms undergoing unilateral or bilateral surgical CSD, ICD shocks were reduced by 90% in 90% of the patients, with left CSD less efficient (50% shock free) than bilateral CSD ( S9.16.10 , S9.16.13 , S9.16.14 ).…”
Section: Mapping and Ablationmentioning
confidence: 99%
See 2 more Smart Citations
“…Persistent CSD is achieved at open surgery (or by video-assisted thoracoscopy) by resecting the lower third to half of the stellate ganglia and the T2 to T4 or T5 thoracic ganglia, as well as transecting the nerve of Kuntz when present ( S9.16.10 ). Potential complications include Horner syndrome, Harlequin syndrome, dyshydrosis, and regional temperature changes ( S9.16.11 , S9.16.12 ). In a series of heterogeneous patients with drug-refractory VA storms undergoing unilateral or bilateral surgical CSD, ICD shocks were reduced by 90% in 90% of the patients, with left CSD less efficient (50% shock free) than bilateral CSD ( S9.16.10 , S9.16.13 , S9.16.14 ).…”
Section: Mapping and Ablationmentioning
confidence: 99%
“…Surgical CSD can be considered for high-risk patients with contraindications for beta blockers, for patients with symptomatic long QT syndrome when beta blockers are not effective, or when ICD therapy is contraindicated or declined ( S9.16.11 , S9.16.12 , S9.16.16 S9.16.18 ). CSD is associated with a significant reduction of events in patients with high-risk long QT syndrome, with a reported 50%–80% long-term success rate ( S9.16.17 S9.16.21 ).…”
Section: Mapping and Ablationmentioning
confidence: 99%
See 1 more Smart Citation
“…Shortterm follow-up a G2-G5 sympathectomy revealed reduction in symptoms, no more requirements for beta blocker therapy and reduced QT interval. We now believe that further follow-up using greater patient numbers will support this target area to sympathectomy as an option for surgical management of long QT syndrome (44).…”
Section: Long Qt Syndromementioning
confidence: 90%
“…In case of lack of response to drug treatment or cardiac arrest, the next step is implantation of a cardioverter-defibrillator or left stellate ganglioectomy (LSG) [18]. Side effects of LSG are: intermittent temperature changes, facial flush, decreased sweating on one side and pain.…”
Section: Treatmentmentioning
confidence: 99%